Bone marrow biopsy (BM) morphology in patients with chronic myeloid leukemia (CML) treated with STI571

被引：0
|
作者：
Chiu, A
Silver, R
Rosamillia, M
Chadburn, A
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY USA
[2] Novartis Pharmaceut AG, Basel, Switzerland
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
934
引用
收藏
页码：159A / 159A
页数：1
相关论文
共 50 条
  • [41] Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: Rapid response to imatinib mesylate (STI571)
    Imashuku, S
    Morimoto, A
    Kuriyama, K
    Kano, G
    Hibi, S
    Todo, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (02): : 159 - +
  • [42] Marrow morphology of chronic myelogenous leukemia in patients treated with imatinib mesylate (Gleevac, Sti-571): Correlation with cytogenetic response
    Racke, F
    Allan, RW
    Miller, C
    Weir, EG
    MODERN PATHOLOGY, 2005, 18 : 248A - 248A
  • [43] Monitoring the response of CML patients treated with STI571 by molecular cytogenetics and quantitative RT-PCR.
    Paschka, P
    Schoch, C
    Lahaye, T
    Weisser, A
    Kuhn, C
    La Rosée, P
    Kreil, S
    Berger, U
    Haferlach, T
    Gschaidmeier, H
    Hehlmann, R
    Hochhaus, A
    BLOOD, 2000, 96 (11) : 734A - 734A
  • [44] Non random chromosomal abnormalities in Ph-negative bone marrow (BM) cells from CML patients achieving major cytogenetic responses (MCR) with STI571 (Gleevec™).
    Gambacorti-Passeri, C
    Giudici, G
    le Coutre, P
    Bungaro, S
    Pogliani, EM
    Kreuzer, KA
    Tornaghi, L
    Alberti, D
    Corneo, G
    Biondi, A
    BLOOD, 2001, 98 (11) : 257B - 258B
  • [45] Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia
    Legros, L
    Bourcier, C
    Jacquel, A
    Mahon, FX
    Cassuto, JP
    Auberger, P
    Pagès, G
    BLOOD, 2004, 104 (02) : 495 - 501
  • [46] Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysis
    Kaneta, Y
    Kagami, Y
    Katagiri, T
    Tsunoda, T
    Jin-nai, I
    Taguchi, H
    Hirai, H
    Ohnishi, K
    Ueda, T
    Emi, N
    Tomida, A
    Tsuruo, T
    Nakamura, Y
    Ohno, R
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (08): : 849 - 856
  • [47] Growth factor mobilization of CD34+ PBSC in CML patients treated with imatinib (STI571).
    Maziarz, RT
    Chauncey, TR
    Capdeville, R
    Druker, BJ
    Seelig, F
    BLOOD, 2001, 98 (11) : 738A - 738A
  • [48] Gleevec (STI-571) for chronic myeloid leukemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1106): : 49 - 52
  • [49] Troxatyl and STI571 combination therapy for chronic myeloid leukemia: Preclinical in vitro and in vivo evaluation.
    Orsolic, N
    Giles, F
    Beran, M
    Cortes, J
    Albitar, M
    Kantarjian, H
    Verstovsek, S
    BLOOD, 2002, 100 (11) : 786A - 786A
  • [50] Imatinib mesylate (STI571) therapy of Philadelphia chromosome-positive chronic myeloid leukemia in early chronic phase (Ph plus CML early CP).
    Kantarjian, HM
    Cortes, J
    O'Brien, S
    Giles, F
    Thomas, D
    Garcia-Manero, G
    Faderl, S
    Rios, MB
    Shan, J
    Hayes, K
    Keating, MJ
    Freireich, EJ
    Talpaz, M
    BLOOD, 2001, 98 (11) : 137A - 137A
12345